Piper Sandler analyst David Westenberg reiterates Zoetis (NYSE:ZTS) with a Overweight and lowers the price target from $220 to $195.
Piper Sandler Reiterates Overweight on Zoetis, Lowers Price Target to $195
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.